Lotus Eye Hospital and Institute Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by S Rajkumar, was filed 19 Jun 2023.
Lotus Eye Hospital and Institute Limited: what insiders have been doing
Every trade that managers of Lotus Eye Hospital and Institute Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 1 filing came from 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (1,890 companies, median 4 filings), a count of 1 filing is below the norm. Since 2022, the database holds 2 purchases and 4 sales by insiders of the company.
No insider has bought Lotus Eye Hospital and Institute Limited shares on the open market in the past twelve months.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,428,571 shares-Inter-se TransferSEBI:9927489c77208370d7b5c6cba72d435d497701c3
- 130,934 shares@ ₹57.19412.8% of flowEquity SharesSEBI:1dba38d18105aaf0a61644b32ab131ee16f7f14b
- 109,489 shares@ ₹57.04092.3% of flowEquity SharesSEBI:3ec45bbbf5c50d7010e0e0d8f9ea04e18143aeff
- 3,158,191 shares@ ₹54.867463.3% of flowEquity SharesSEBI:49020648ed052e297bd80f784b8e7b18356c5ace
- 500,000 shares@ ₹63.0011.4% of flowEquity SharesSEBI:70ea168b4c1f42398cec65d77fda0b73b96c1ba3
- 207,000 shares@ ₹84.95216.4% of flowEquity SharesSEBI:5bd1ff4d1d497f41eb01f7400330a483b5b780fd
- 19,664 shares@ ₹83.98180.6% of flowEquity SharesSEBI:ea10ee9142faf46b5ba4a74e98b16d4da3d0822dCanonical exit: 7 Sept 2023 (T+90)
- 24,106 shares@ ₹79.49630.7% of flowEquity SharesSEBI:ef4d122d13d1de7cf33c1f920bfb341a79df71a3Canonical exit: 31 Aug 2023 (T+90)
- 3,682,307 shares@ ₹8.554412.6% of flowEquity SharesSEBI:33d0805e0063faceceddcf221aac87a54ee455e9
9 of 9 declarations
About Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited is a healthcare facility specializing in eye care in India. It provides a range of services from consultations to surgical interventions.
